Literature DB >> 27230363

CANCER. The cancer predisposition revolution.

David Malkin1, Judy E Garber2, Louise C Strong3, Stephen H Friend4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27230363     DOI： 10.1126/science.aag0832

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

1.  Stem cells: Subclone wars.

Authors:  Stephen Chanock
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962

Review 2.  Germline Genetic Predisposition to Hematologic Malignancy.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

3.  De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

Authors:  Tsutomu Toki; Kenichi Yoshida; RuNan Wang; Sou Nakamura; Takanobu Maekawa; Kumiko Goi; Megumi C Katoh; Seiya Mizuno; Fumihiro Sugiyama; Rika Kanezaki; Tamayo Uechi; Yukari Nakajima; Yusuke Sato; Yusuke Okuno; Aiko Sato-Otsubo; Yusuke Shiozawa; Keisuke Kataoka; Yuichi Shiraishi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kiminori Terui; Tomohiko Sato; Takuya Kamio; Hirotoshi Sakaguchi; Shouichi Ohga; Madoka Kuramitsu; Isao Hamaguchi; Akira Ohara; Hitoshi Kanno; Satoru Miyano; Seiji Kojima; Akira Ishiguro; Kanji Sugita; Naoya Kenmochi; Satoru Takahashi; Koji Eto; Seishi Ogawa; Etsuro Ito
Journal:  Am J Hum Genet       Date:  2018-08-23       Impact factor: 11.025

4.  Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.

Authors:  Nicholas W Fischer; Aaron Prodeus; Jean Gariépy
Journal:  JCI Insight       Date:  2018-08-09

5.  Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology.

Authors:  Bernd L Groner; Nancy E Hynes
Journal:  PLoS Biol       Date:  2016-09-29       Impact factor: 8.029
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.